eClinical Tech News

Tangram Therapeutics has submitted a Clinical Trial Application to the UK’s MHRA for TGM-312, a GalNAc-conjugated siRNA targeting a...

Nurexone Biologic reported a busy third quarter: the exosome-focused biotech secured roughly C$4.6 million in fresh capital through accelerated...

Tangram Therapeutics has submitted a Clinical Trial Application to the UK MHRA to initiate a Phase 1/2 study of...

Eisai has filed a new drug application with Japan’s PMDA for a subcutaneous autoinjector formulation of lecanemab (Leqembi), seeking...

Valneva reported positive final Phase 2 immunogenicity and safety data for VLA15, the Pfizer-partnered Lyme disease vaccine, showing robust...

Valneva reported final Phase 2 immunogenicity and safety data for VLA15, the multivalent Lyme disease vaccine co-developed with Pfizer,...

Bayer has secured FDA accelerated approval for Hyrnuo (sevabertinib), a reversible HER2 tyrosine kinase inhibitor, for adults with locally...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty valued up to $71 million, securing $50 million upfront...

Nanobiotix has closed a non-dilutive royalty financing with Healthcare Royalty worth up to $71 million, securing $50 million upfront...

Praxis Precision Medicines will use the American Epilepsy Society meeting in Atlanta on December 5–9, 2025 to unveil new...